Development and landscape of maintenance therapy after first-line treatment of advanced or metastatic urothelial carcinoma

Development and landscape of maintenance therapy after first-line treatment of advanced or metastatic urothelial carcinoma

Overall survival (OS) in patients with advanced or metastatic urothelial carcinoma (UC) is not optimistic. For a long time, the standard platinum-based chemotherapy has been one of the preferred treatment strategies. Despite the high initial objective response rate (ORR) to first-line chemotherapy i...

Full description

Saved in:
Bibliographic Details
Main Authors: Zengguang Liu, Xiaofeng Cong, Chen Chen, Jiaxin Yin, Ziling Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Immunology
Subjects:
maintenance therapy
urothelial carcinoma (UC)
advanced
metastatic
avelumab
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1541213/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items